Fluidigm to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Fluidigm Corporation (NASDAQ:FLDM) today announced that President and Chief Executive Officer Gajus Worthington will present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15 at the Encore at Wynn Las Vegas, beginning at 3:40 p.m. Pacific Time.

Audio and slides of Fluidigm’s presentation will be webcast at: http://www.veracast.com/webcasts/baml/healthcare2013/id47464430.cfm

The webcast will be archived for 90 days following the live presentation.

About Fluidigm

Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets microfluidic systems to leading academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing. Fluidigm’s proprietary microfluidic systems consist of instruments and consumables, including 13 different commercial integrated fluidic circuits (IFCs) for nucleic acid analysis, and three families of assay chemistries. These systems are designed to significantly simplify experimental workflow, increase throughput, and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm products are provided: “For Research Use Only. Not for use in diagnostic procedures.”

For more information, please visit www.fluidigm.com.

Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.